United States - English - NLM (National Library of Medicine)

acella pharmaceuticals, llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), calcium (unii: sy7q814vup) (calcium - unii:sy7q814vup), ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), pyridoxine (unii: kv2jz1bi6z) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), doconexent (unii: zad9okh9jc) (doconexent - unii:zad9okh9jc) - ascorbic acid 28 mg - pnv-dha + docusate is a prescription prenatal/postnatal multivitamin/multimineral softgel with dha. each softgel is red in color and imprinted with “323” on one side. † daily value (dv) not established. bovine gelatin, glycerin, soybean oil, soy lecithin, purified water, yellow beeswax, fd&c red # 40, titanium dioxide, orange cream flavor, ethyl vanillin, fd&c yellow # 6, and fd&c blue #1. contains soy. pnv-dha + docusate is a multivitamin/mineral prescription dietary supplement indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - eicosapentaenoic acid; docosahexaenoic acid - oral capsule - 460mg ; 380mg

United States - English - NLM (National Library of Medicine)

carwin pharmaceutical associates, llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol, d- (unii: n9pr3490h9) (.alpha.-tocopherol, d- - unii:n9pr3490h9), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), iron (unii: e1uol152h7) - tristart™ free is a dietary supplement indicated to provide vitamin, mineral and dha supplementation throughout pregnancy and in the postnatal period. tristart™ free should not be used by patients with a known history of hypersensitivity to any of the listed ingredients.

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

linoleic acid, vitamin b6, folic acid, docosahexaenoic acid, calcium, taurine, inositol, phosphorus, vitamin e, vitamin a, casein protein, uridin-5-monophosphate disodium salt, alpha linolenic acid, iodine, fibre, pantothenic acid, dextrins, chloride, vitamin b12, vitamin k1, vitamin b2, cytidin-5-monophosphoric acid, l-carnitine, iron, biotin, potassium, whey protein, vitamin b1, arachidonic acid, selenium, saturated fatty acids, inosine-5-monophosphate disodium salt, copper, alpha lactalbumin, sodium, nia -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

blackmores limited - linolenic acid; linoleic acid; docosahexaenoic acid; eicosapentaenoic acid - oral paste - linolenic acid acid-essential fatty active 120.0 mg; linoleic acid acid-essential fatty active 38.0 mg; docosahexaenoic acid acid-fatty active 59.0 mg; eicosapentaenoic acid acid-fatty active 85.0 mg - nutrition & metabolism - dog | bitch | castrate | puppy - dermatological condition | flea allergic dermatitis

United States - English - NLM (National Library of Medicine)

meda pharmaceuticals - doconexent (unii: zad9okh9jc) (doconexent - unii:zad9okh9jc), icosapent (unii: aan7qov9ea) (icosapent - unii:aan7qov9ea), calcium (unii: sy7q814vup) (calcium - unii:sy7q814vup), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), pyridoxine (unii: kv2jz1bi6z) (pyridoxine - unii:kv2jz1bi6z), .alpha.-tocopherol (unii: h4n855pnz1) (.alpha.-tocopherol - unii:h4n855pnz1), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8) - doconexent 250 mg - natelle® one is indicated to provide vitamin/mineral and dha omega–3 fatty acid supplementation to women throughout pregnancy, during the postnatal period for both lactating and non–lactating mothers, and throughout the childbearing years. natelle® one may be beneficial in improving the nutritional status of women prior to conception. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

United States - English - NLM (National Library of Medicine)

puretek corporation - thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), ferrous fumarate (unii: r5l488ry0q) (ferrous c - thiamine 3 mg - prenatal + dha™ is indicated to provide vitamin/mineral and dha omega-3 fatty acid supplement to women throughout pregnancy, during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years. prenatal + dha™ may be beneficial in improving the nutritional status of women prior to conception. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

United States - English - NLM (National Library of Medicine)

par pharmaceutical inc. - omega-3-acid ethyl esters (unii: d87ygh4z0q) (omega-3 fatty acids - unii:71m78end5s) - omega-3-acid ethyl esters 900 mg - omega-3-acid ethyl esters capsules, usp are indicated as an adjunct to diet to reduce triglyceride (tg) levels in adult patients with severe (≥500 mg/dl) hypertriglyceridemia (htg). usage considerations: patients should be placed on an appropriate lipid-lowering diet before receiving omega-3-acid ethyl esters capsules, usp and should continue this diet during treatment with omega-3-acid ethyl esters capsules, usp. laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting  therapy with omega-3-acid ethyl esters. every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities. medications known to exacerbate hypertriglyceridemia (such as beta blockers, thiazides, estrogens) should be discontinued or changed if possible prior to consideration of triglyceride-lowering drug ther

United States - English - NLM (National Library of Medicine)

golden state medical supply, inc. - omega-3-acid ethyl esters (unii: d87ygh4z0q) (omega-3 fatty acids - unii:71m78end5s) - omega-3-acid ethyl esters 900 mg - -  omega-3-acid ethyl esters is indicated as an adjunct to diet to reduce triglyceride (tg) levels in adult patients with severe (≥500 mg/dl) hypertriglyceridemia (htg). -   usage considerations: patients should be placed on an appropriate lipid-lowering diet before receiving omega-3-acid ethyl esters and should continue this diet during treatment with omega-3-acid ethyl esters. -  laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting therapy with omega-3-acid ethyl esters. every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities. medications known to exacerbate hypertriglyceridemia (such as beta blockers, thiazides, estrogens) should be discontinued or changed if possible prior to consideration of triglyceride-lowering drug therapy. -  

United States - English - NLM (National Library of Medicine)

northstar rx llc - omega-3-acid ethyl esters (unii: d87ygh4z0q) (omega-3 fatty acids - unii:71m78end5s) - omega-3-acid ethyl esters 1 g - omega-3-acid ethyl esters capsules are indicated as an adjunct to diet to reduce triglyceride (tg) levels in adult patients with severe (greater than or equal to 500 mg per dl) hypertriglyceridemia (htg). usage considerations: patients should be placed on an appropriate lipid-lowering diet before receiving omega-3-acid ethyl esters capsules and should continue this diet during treatment with omega-3-acid ethyl esters capsules. laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting therapy with omega-3-acid ethyl esters capsules. every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities. medications known to exacerbate hypertriglyceridemia (such as beta blockers, thiazides, estrogens) should be discontinued or changed if possible prior to consideration of triglyceri